L218-0085 Screening compound: 2-[2-(4-chlorophenyl)-4-oxopyrimido[1,2-a][1,3]benzimidazol-10(4H)-yl]-N~1~-cyclopentylacetamide

L218-0085 Screening compound: 2-[2-(4-chlorophenyl)-4-oxopyrimido[1,2-a][1,3]benzimidazol-10(4H)-yl]-N~1~-cyclopentylacetamide
L218-0085 Screening compound: 2-[2-(4-chlorophenyl)-4-oxopyrimido[1,2-a][1,3]benzimidazol-10(4H)-yl]-N~1~-cyclopentylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L218-0085
2-[2-(4-chlorophenyl)-4-oxopyrimido[1,2-a][1,3]benzimidazol-10(4H)-yl]-N~1~-cyclopentylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L218-0085

Molecular Formula

C23H21ClN4O2 (C23 H21 ClN4 O2)

Compound Name

2-[2-(4-chlorophenyl)-4-oxopyrimido[1,2-a][1,3]benzimidazol-10(4H)-yl]-N~1~-cyclopentylacetamide

IUPAC name

2-[11-(4-chlorophenyl)-13-oxo-1810-triazatricyclo[7.4.0.0^{27}]trideca-246911-pentaen-8-yl]-N-cyclopentylacetamide

SMILES

O=C(CN(c(cccc1)c1N12)C2=NC(c(cc2)ccc2Cl)=CC1=O)NC1CCCC1

InChI

InChI=1S/C23H21ClN4O2/c24-16-11-9-15(10-12-16)18-13-22(30)28-20-8-4-3-7-19(20)27(23(28)26-18)14-21(29)25-17-5-1-2-6-17/h3-4,7-13,17H,1-2,5-6,14H2,(H,25,29)

InChI Key

NVTXCVJMCMDSIH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD18171630

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

420.9

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.611

Distribution Coefficient, logD

3.611

Water Solubility, LogSw

-4.15

Polar Surface Area

52.647

Acid Dissociation Constant (pKa)

16.49

Base Dissociation Constant (pKb)

2.09

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.10

L218-0085 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Proteases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L218-0085 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L218-0085?
Check Price and Availability of L218-0085, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L218-0085 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L218-0085
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L218-0085
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L218-0085 available by request